Physicians-in-training are not prepared to prescribe medical marijuana

Abstract

Background While medical marijuana use is legal in more than half of U.S. states, evidence is limited about the preparation of physicians-in-training to prescribe medical marijuana. We asked whether current medical school and graduate medical educational training prepare physicians to prescribe medical marijuana. Methods We conducted a national survey of U.S. medical school curriculum deans, a similar survey of residents and fellows at Washington University in St. Louis, and a query of the Association of American Medical Colleges (AAMC) Curriculum Inventory database for keywords associated with medical marijuana. Results Surveys were obtained from 101 curriculum deans, and 258 residents and fellows. 145 schools were included in the curriculum search. The majority of deans (66.7%) reported that their graduates were not at all prepared to prescribe medical marijuana, and 25.0% reported that their graduates were not at all prepared to answer questions about medical marijuana. The vast majority of residents and fellows (89.5%) felt not at all prepared to prescribe medical marijuana, while 35.3% felt not at all prepared to answer questions, and 84.9% reported receiving no education in medical school or residency on medical marijuana. Finally, only 9% of medical school curriculums document in the AAMC Curriculum Inventory database content on medical marijuana. Conclusions Our study highlights a fundamental mismatch between the state-level legalization of medical marijuana and the lack of preparation of physicians-in-training to prescribe it. With even more states on the cusp of legalizing medical marijuana, physician training should adapt to encompass this new reality of medical practice.

Emerging Evidence for Cannabis' Role in Opioid Use Disorder

“… 169 This is unsurprising, given that 85% of recent medical school graduates still receive no education whatsoever about cannabis throughout their training, residencies, or fellowships. 170 As the evidence in this field accumulates, it will be critically important to widen opportunities for clinicians to participate in Continuing Medical Education programs, which include the harm reduction and medical benefits that cannabis could provide. Evidence-based opioid prescription and cannabis recommendation practices are a critical component of continuing education, so that clinicians can continue to uphold their Hippocratic oaths to “do no harm.”…”

Public interest in Cannabis during election season: a Google Trends analysis

“…Second, we recommend educating physicians on the inherent conflicts of interest within cannabis legislation and the difficulties in conducting clinical trials to provide evidence for its effectiveness (Hill 2019;Bowling and Glantz 2019). Lastly, given that many resident and fellow physicians report having little knowledge about medicinal cannabis, we suggest that efforts be made to educate and train future physicians on the risks and benefits of cannabis (Evanoff et al 2017). One avenue to this education could be implementing cannabis education into the curriculum of medical schools and post-graduate residency programs.…”

Uso medicinal de cannabis: una revisión de la evidencia

“…La gran mayoría de los residentes y becarios (89.5 %) no se sintieron capacitados para recetar cannabis medicinal, mientras que el 35.3 % no se sintieron preparados para responder preguntas. El 84.9 % informó que no recibió educación en la escuela de medicina o residencia sobre cannabis medicinal (Evanoff, Quan, Dufault, Awad, & Bierut, 2017). La falta de preparación y la importancia de la salud de los usuarios hace imperativo que los médicos tengan cuidado al recomendar el UMC (Choi, DiNitto, & Marti, 2017;Deshpande, Mailis-Gagnon, Zoheiry, & Lakha, 2015).…”